<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863043</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.183</article-id><article-id pub-id-type="other">O0053</article-id><article-id pub-id-type="pii">S0924933824001834</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>Oral Communication</subject></subj-group></article-categories><title-group><article-title>Mental Health and Addictions in Pregnancy: Feasibility and Acceptability of a Computerized Clinical Pathway and Prevalence Rates</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Carmona Camacho</surname><given-names>R.</given-names></name><xref rid="aff0190" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0044" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chamorro Delmo</surname><given-names>J.</given-names></name><xref rid="aff0190" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Alvaro Navidad</surname><given-names>M.</given-names></name><xref rid="aff0191" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lopez Carpintero</surname><given-names>N.</given-names></name><xref rid="aff0192" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Estrella Sierra</surname><given-names>N.</given-names></name><xref rid="aff0193" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Guimaraes de Oliveira</surname><given-names>R.</given-names></name><xref rid="aff0194" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Olhaberry Huber</surname><given-names>M.</given-names></name><xref rid="aff0195" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mata Iturralde</surname><given-names>L.</given-names></name><xref rid="aff0190" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>&#x000c1;lvarez Garc&#x000ed;a</surname><given-names>R.</given-names></name><xref rid="aff0196" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Baca Garcia</surname><given-names>E.</given-names></name><xref rid="aff0190" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff0190">
<sup>1</sup>Psychiatry</aff><aff id="aff0191">
<sup>2</sup>Obstetrics and ginecology, Jimenez Diaz Foundation</aff><aff id="aff0192">
<sup>3</sup>Obstetrics and ginecology, Tajo University Hospital</aff><aff id="aff0193">
<sup>4</sup>Psychiatry, Infanta Elena University Hospital, <city>Madrid</city>, <country>Spain</country></aff><aff id="aff0194">
<sup>5</sup>Child and Adolescent Psychiatry, Hassenfeld Children&#x02019;s Hospital at NYU Langone, <city>
New York</city>, <country>United States</country></aff><aff id="aff0195">
<sup>6</sup>Psychology, Pontificia Universidad Cat&#x000f3;lica de Chile, <city>Santiago</city>, <country>Chile</country></aff><aff id="aff0196">
<sup>7</sup>Psychiatry, Rey Juan Carlos University Hospital, <city>Madrid</city>, <country>Spain</country></aff><author-notes><corresp id="cor0044"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="158">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S66</fpage><lpage>S67</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824001834a.pdf"/><abstract><sec id="sec0261"><title>Introduction</title><p>Mental Health problems and substance misuse during pregnancy constitute a serious social problem due to high maternal-fetal morbidity (Cook et al, 2017; JOCG, 39(10) ,906-915)&#x000a0;and low detection and treatment rates (Carmona et al. Adicciones. 2022;34(4):299-308)</p></sec><sec id="sec0262"><title>Objectives</title><p>Our study aimed to develop and test the feasibility and acceptability of a screening and treatment clinical pathway in pregnancy, based on the combination of e-Health tools with in-person interventions and, secondly, describe the prevalence of mental illness and substance use problems in this population.</p></sec><sec id="sec0263"><title>Methods</title><p>1382 pregnant women undergoing her first pregnancy visit were included in a tailored clinical pathway and sent a telematic (App) autoapplied questionnaire with an extensive battery of measures (WHO (Five) Well-Being [WHO-5],Patient Health Questionnaire [PHQ-9], General Anxiety Disorder [GAD-7], Alcohol Use Disorders Identification Test [AUDIT], Drug Abuse Screening Test [DAST], Columbia Suicide Severity Rating Scale [C-SSRS] and specifically designed questions on self-harm and psychopharmacological drugs).</p><p>Patients who did not respond to the questionnaire on their own received a counseling call.</p><p>Based on the screening results, patients were classified into five groups according to severity (Figure 1) and assigned a specific action pathway (Figure 2) that included a range of intervention intensity that goes from an individual psychiatric appointment to no intervention.</p></sec><sec id="sec0264"><title>Results</title><p>Of the 1382 women included in the clinical pathway, 565(41%) completed the evaluation questionnaires.&#x000a0;Of these, 205 (36%) were screened as positive (Grades III,IV or V. Table 1) and 3(0.5%) were classified as needing urgent care. Of the patients offered on-line groups (100), 40% (40) were enrolled in them.<table-wrap position="anchor" id="tab3"><label>
Table 1:</label><caption><p>Grade distribution of those screened as positives</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Grade III</td><td align="left" valign="middle" rowspan="1" colspan="1">97 (17,2%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Grade IV</td><td align="left" valign="middle" rowspan="1" colspan="1">105 (18,6%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Grade V</td><td align="left" valign="middle" rowspan="1" colspan="1">3 (0,5%)</td></tr></tbody></table><graphic xlink:href="S0924933824001834-FIG0193" position="anchor"/></alternatives></table-wrap>
</p><p>Concerning prevalence rates, 73 (12,9%) patients endorsed at least moderate anxiety according to GAD-7 (&#x02265;10), 65 (11,5%) endorsed at least moderate depression according to PHQ-9 (&#x02265; 10), 17 were positive on DAST (3%)&#x000a0;and 63 (11%) patients scored above the threshold in AUDIT-C(&#x02265; 3) for alcohol use.</p><p><bold>Image:</bold>
</p><p><fig position="float" id="fig0193"><graphic xlink:href="S0924933824001834-FIG0194" position="anchor"/></fig>
</p><p>
<bold>Image 2:</bold>
</p><p><fig position="float" id="fig0194"><graphic xlink:href="S0924933824001834-TABU0003" position="anchor"/></fig>
</p></sec><sec id="sec0265"><title>Conclusions</title><p>High prevalence rates suggest that effective detection and treatment mechanisms should be integrated into usual care. The use of standardized clinical pathways can help with this aim, allowing better clinical management and referral to treatment, but still face challengues to increase retention. The use of e-health tools offers the opportunity to improve accessibility and therapeutic outcomes through online interventions.</p></sec><sec id="sec0266"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>